Showing 701 - 720 results of 10,572 for search '"tumors"', query time: 0.12s Refine Results
  1. 701
  2. 702

    Enhanced Brain Tumor Classification through Gamma Correction in Deep Learning by Muhammad Naufal, Harun Al Azies, Rivaldo Mersis Brilianto

    Published 2024-11-01
    “…This study classifies three classes of brain tumors: gliomas, meningiomas, and pituitary tumors. …”
    Get full text
    Article
  3. 703

    Inflammatory Myofibroblastic Tumor: A Rarely Seen Submucosal Lesion of the Stomach by Deniz Arslan, Şeyda Gündüz, Deniz Tural, Mükremin Uysal, Ali Murat Tatlı, Cumhur İbrahim Başsorgun, Gülsüm Özlem Elpek, Hasan Şenol Coşkun, Hakan Şat Bozcuk, Burhan Savaş

    Published 2013-01-01
    “…Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal benign tumor which is generally seen in children and in young adults. …”
    Get full text
    Article
  4. 704

    Renal Peripheral Neuroectodermal Tumor Presenting at Age 78: Case Report by Michelle E. Koski, Jason M. Tedesco, Peter E. Clark

    Published 2008-01-01
    “…Primitive neuroectodermal tumor (PNET) of the kidney is a rare and aggressive tumor, often presenting in advanced stages and progressing rapidly. …”
    Get full text
    Article
  5. 705
  6. 706

    First Description of the Clinical Activity of Avapritinib in Sporadic Mesenteric Desmoid Tumor by Rebecca Ganzon, Wei Chen, Gabriel Tinoco

    Published 2024-01-01
    “…Desmoid tumors (DTs) are rare and locally aggressive with a high rate of local recurrence even with optimal surgical resection. …”
    Get full text
    Article
  7. 707
  8. 708

    Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept by Guido Giordano, Antonio Febbraro, Michele Venditti, Serena Campidoglio, Nunzio Olivieri, Katia Raieta, Pietro Parcesepe, Giusy Carmen Imbriani, Andrea Remo, Massimo Pancione

    Published 2014-01-01
    “…Accordingly, novel antiangiogenic targeted agents bevacizumab, regorafenib, and aflibercept have been approved for mCRC treatment as the result of several phase III randomized trials. The development of a tumor permissive microenvironment via the aberrant expression by tumor cells of paracrine factors alters the tumor-stroma interactions inducing an expansion of proangiogenic signals. …”
    Get full text
    Article
  9. 709
  10. 710

    Tumor de vías excretoras urinarias superiores. Presentación de caso by Masleidy Valladares Valle, Nery María Díaz Yanes, Luciano Núñez Almoguea, Bárbara Miladis Depestre Rabí

    Published 2021-06-01
    “…Los tumores del tracto urinario superior representan menos del 5 % de todas las neoplasias uroteliales, con un porcentaje de recurrencia superior al 90 % y una supervivencia a los 5 años que oscila entre el 30-60 %. …”
    Get full text
    Article
  11. 711
  12. 712
  13. 713
  14. 714

    Arginase-1-specific T cells target and modulate tumor-associated macrophages by Mads Hald Andersen, Inés Lecoq, Ayako Wakatsuki Pedersen, Evelina Martinenaite, Shamaila Munir Ahmad, Maria Perez-Penco, Lucia Lara de la Torre, Marion Chapellier, Lars Rønn Olsen, Mia Aaboe-Jørgensen, Hannah Jorinde Glöckner, Anne Mette Askehøj Rømer

    Published 2025-01-01
    “…Background Arginase-1 (Arg1) expressing tumor-associated macrophages (TAMs) may create an immune-suppressive tumor microenvironment (TME), which is a significant challenge for cancer immunotherapy. …”
    Get full text
    Article
  15. 715

    Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination by Mathias Vormehr, Barbara Schrörs, Sebastian Boegel, Martin Löwer, Özlem Türeci, Ugur Sahin

    Published 2015-01-01
    “…Due to their absence during negative selection of T cells and their lack of expression in healthy tissue, tumor mutations are considered as optimal targets for cancer immunotherapy. …”
    Get full text
    Article
  16. 716
  17. 717

    Primary Small Cell Carcinoma of the Larynx: Report of a Rare Tumor by Harmeet Singh, Ashok Chauhan

    Published 2011-01-01
    “…Primary small cell carcinoma of larynx is a rare tumor representing less than 0.5% of all laryngeal cancers. …”
    Get full text
    Article
  18. 718
  19. 719
  20. 720

    The lysosome-related characteristics affects the prognosis and tumor microenvironment of lung adenocarcinoma by Wuguang Chang, Wuyou Gao, Yawei Wu, Bin Luo, Lekai Zhong, Leqi Zhong, Wenqian Lin, Zhesheng Wen, Youfang Chen

    Published 2025-01-01
    “…BackgroundThe lysosome plays a vitally crucial role in tumor development and is a major participant in the cell death process, involving aberrant functional and structural changes. …”
    Get full text
    Article